CompletedNo phase
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Key facts
- Who runs it
- Medtronic Endovascular
- Where
- Brooklyn, Naples, New York, Plano, Scottsdale, and Washington D.C., United StatesSee the 6 sites
- Trial code
- Status
- Completed
- People taking part
- 51 people enrolled
- Started
- 24 Feb 2026
- Ended
- 30 Oct 2026
- Type of study
- Observational
- Treatments tested
- Liberant Thrombectomy System
- Record updated
- 6 November 2026
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Other criteria
- Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria:
- Patient treated is age ≥ 22 years at the time of procedure
- Use of Liberant in accordance with the device labeling within 72 hours of index procedure
Where in United States
- NewYork-Presbyterian Medical Group BrooklynBrooklyn, United StatesNo longer taking part
- Naples Comprehensive HealthNaples, United StatesNo longer taking part
- Mount SinaiNew York, United StatesNo longer taking part
- Baylor Heart Hospital Of PlanoPlano, United StatesNo longer taking part
- HonorHealth Heart Care - Vascular - OsbornScottsdale, United StatesNo longer taking part
- MedStar HealthWashington D.C., United StatesNo longer taking part
About the trial
What the trial wants to find out
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
Treatments tested
- Liberant Thrombectomy System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 6 November 2026